Paradeep Phosphates

As of 2026-11-06, PARADEEP trades at ₹142.01, reflecting a mixed technical posture across timeframes. The daily trend is bearish and established (ADX 33.31), with price below the Supertrend and key moving averages (50-day EMA/SMA), despite being above the 200-day SMA. This contrasts with a bullish weekly Supertrend and weak monthly momentum (ADX 13.41). Recent volatility is high, marked by an extreme volume-price anomaly on 2026-10-30 (-7.6% return, 15.46x volume ratio) and failed bullish engulfing patterns in early November. Price sits in the upper-middle of its 20-day range (+69.5%) but remains in a significant drawdown (-38.7%). Immediate resistance lies at ₹142.44 (0.31% above) and ₹143.69 (1.18% above), while support is found at ₹141.59 (0.30% below) and ₹140.64 (0.97% below). A break below ₹140.64 would invalidate the short-term consolidation structure.

On 4 November 2026, Prabhudas Lilladher issued a research note recommending an 'Accumulate' rating for Paradeep Phosphates. The broker set a price target of ₹148, suggesting the stock has potential upside from its current trading levels based on their analysis. This is an external analyst opinion and does not reflect a corporate announcement or verified operational development by the company itself.

Paradeep Phosphates Limited reported unaudited financial results for Q2 and H1 FY2027, revealing a significant divergence between top-line growth and bottom-line profitability. Revenue from operations rose 7% year-over-year to ₹7,364 crore in Q2, driven by sales volumes of 1 million tons despite subdued monsoon conditions. However, profitability metrics contracted sharply: EBITDA fell 38% to ₹431 crore, PBT dropped 65% to ₹164 crore, and PAT decreased 64% to ₹122 crore. For the half-year, turnover reached ₹13,488 crore (up 19% YoY), but PAT declined 21.8% to ₹5,156 crore. Management attributed margin pressure to supply-chain disruptions, higher freight, insurance, and raw-material costs amid West Asia tensions, alongside an inventory write-down of ₹59.98 crore recognized under Ind AS 2. On the operational front, the company completed an energy efficiency project at its Goa facility and is progressing with Phase 1 of the Phos Acid expansion at Paradeep, targeting capacity growth from 500,000 MTPA to 700,000 MTPA; environmental approvals are expected shortly following completed public hearings. The Board also finalized the provisional purchase price allocation for the acquisition of Mangalore Chemicals and Fertilizers Limited with no adjustments required.

Paradeep Phosphates reported a sharp deceleration in profitability for Q2 FY2026-27, with net profit falling to ₹121 crore from ₹393 crore in the prior quarter. While sales growth remained positive at 7% year-on-year (₹7,382 crore), expenses surged significantly, rising to ₹7,218 crore and compressing margins. This earnings contraction coincides with deteriorating cash conversion; CFO/EBITDA turned negative (-33%) in FY2026, and operating cash flow swung to -₹1,012 crore, contrasting sharply with the robust +₹1,648 crore generated in FY2025.

The balance sheet reflects an aggressive expansion phase. Total borrowings rose to ₹9,879 crore by September 2026, driven largely by current borrowings jumping to ₹8,853 crore. Fixed assets increased to ₹6,193 crore, while Capital Work-in-Progress (CWIP) declined to ₹283 crore, indicating that major projects are nearing completion. However, working capital efficiency has weakened, with the Cash Conversion Cycle extending to 115 days from 74 days in FY2025, primarily due to Inventory Days rising to 105 days. Despite these near-term pressures, long-term fundamentals remain stable, with ROCE holding at 15% and promoter stake increasing to 57.85%.

Paradeep Phosphates exhibits significant technical weakness and elevated volatility as of November 6, 2026. The stock is trading at ₹142.01, well below the broker target of ₹148, with a daily Supertrend indicating a bearish trend. Momentum indicators are negative: the Plus DI (15.1) is substantially lower than the Minus DI (33.64), and both the 20-day EMA and SMA show downward slopes over the last five periods. Performance metrics reflect this deterioration, with year-to-date returns at -13.9% and a one-year return of -13.3%. The stock has experienced a current drawdown of -38.7%, approaching its historical maximum drawdown of -55.4%, while annualized volatility stands high at +47.4%. Although the weekly timeframe shows a bullish Supertrend, the immediate daily pressure suggests limited near-term upside potential despite the 'Accumulate' recommendation.